Glow 70

Why Researchers Choose Glow 70

Glow 70 is a 70mg growth-hormone-axis blend built to study visceral fat reduction, the intra-abdominal fat surrounding the intestines, liver and pancreas. This depot matters because it behaves very differently from subcutaneous fat:

• It is more metabolically active than subcutaneous fat
• It is a major source of portal free fatty acids that drive hepatic insulin resistance
• It produces inflammatory adipokines such as TNF-alpha, IL-6 and resistin
• It is closely linked to cardiovascular risk, type 2 diabetes and metabolic syndrome
• It is the fat depot most responsive to growth-hormone-driven lipolysis
• Its reduction tracks with improved lipid profile and insulin sensitivity in research

Unlike subcutaneous fat, visceral adipose tissue is particularly sensitive to GH-driven lipolysis, which is why optimising the growth-hormone axis is a targeted route to visceral fat specifically.

How the Three Components Work Together

Tesamorelin: a full-length GHRH analogue and the reference clinical compound for GH-based fat loss, FDA-approved for visceral fat reduction. It raises endogenous growth hormone in a sustained, physiological pattern.

Ipamorelin: a selective GH secretagogue (GHS-R1a agonist) that amplifies each GH pulse through a separate receptor mechanism. Layered onto the tesamorelin signal, it produces larger pulses and greater lipolytic drive without disturbing cortisol or prolactin.

AOD 9604: the C-terminal fragment of growth hormone, which activates beta-adrenergic signalling inside adipocytes independently of the GH receptor and GH-stimulated IGF-1. It adds a direct, receptor-independent route to lipolysis.

Kit Contents and Administration

Glow 70 ships as a single 70mg vial. Contents and per-component dosing are detailed on the product label, with each peptide sourced from Milo-Lab’s standard product line at kit pricing. It is reconstituted and used by subcutaneous injection in research settings.

Reconstitution and Storage

Reconstitution: reconstitute the vial with bacteriostatic water; swirl gently until dissolved, do not shake. After reconstitution: keep refrigerated, protect from direct light, and use within 28 days.

For research purposes only. Not for human consumption.